Pharmacogenomics Market is estimated to be US$ 58.3 billion by 2034 with a CAGR of 12.2% during the forecast period

The study of inherited changes in human genes in response to various medications is known as pharmacogenomics. It employs pharmacology and genomics principles to create effective and safe pharmaceuticals that are tailored to a person's genetic composition. Polymerase chain reaction (PCR), microarray, deoxyribonucleic acid (DNA) sequencing, mass spectrometry, and electrophoresis are some of the technologies used. The genetic testing used in pharmacogenomics are used to determine illness susceptibility and the efficacy of newly discovered medications. Cardiovascular, Alzheimer's, cancer, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), and asthma are among the disorders for which pharmacogenomics is commonly employed.Pharmacogenomics Market accounted for US$ 20.4 billion in 2024 and is estimated to be US$ 58.3 billion by 2034 and is anticipated to register a CAGR of 12.2% 

The report " Global Pharmacogenomics Market, by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), By Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and By End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2034’’

Key Highlights:

• Green Shield, a Canadian corporation, signed a joint venture with GenXys, a pharmacogenomics company, in May of 2020. They wanted to create effective software for researching and producing precision medications that would result in favourable outcomes.
• KPMG and Coriell Life Sciences and Thermo Fisher Scientific created a joint venture in August of this year. They collaborated on a number of pharmacogenomics testing methodologies. They attempted to improve the drug's efficacy and security.
• Genotyping was identified as the leading contributor to the worldwide pharmacogenomics services market in 2018. Overall effectiveness rates have improved as a result of this.

Analyst View:

One of the primary drivers driving the market's favourable outlook is significant growth in the pharmaceutical business around the world. Furthermore, the growing demand for precision medicines with improved medication safety is propelling the industry forward. With the rising frequency of chronic lifestyle diseases, tailored medication therapies with fewer side effects and higher efficacy are becoming increasingly popular. As a result, pharmacogenomics is widely employed in cancer therapies and for predicting prospective drug responses, resistance, efficacy, and toxicity of chemotherapeutic and targeted immune biologic drugs, which is further driving market expansion. Other growth-inducing elements include numerous technology developments, such as the creation of pharmacogenomic biomarker labelling systems.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Pharmacogenomics Market, by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), By Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and By End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030 and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2034”

Key Market Insights from the report:

Pharmacogenomics Market accounted for US$ 20.4 billion in 2024 and is estimated to be US$ 58.3 billion by 2034 and is anticipated to register a CAGR of 12.2% The Global Pharmacogenomics Market is segmented based on technology, application, end-user and region.

• Based on Technology, Global Pharmacogenomics Market is segmented into Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others.
• Based on Application, Global Pharmacogenomics Market is segmented into Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others.
• Based on End-User, Global Pharmacogenomics Market is segmented into Hospitals & Clinics, Research Institutions and Academic Institutes and Others. 
• By Region, the Global Pharmacogenomics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Pharmacogenomics Market:

The prominent players operating in the Global Pharmacogenomics Market include Abbott Laboratories, Dynamic DNA Laboratories, Empire Genomics, LLC, F. Hoffmann-La Roche Ltd., Illumina, Inc., OneOme LLC, Myriad Genetics Inc., OPKO Health, Inc. (GeneDx), and Thermo Fisher Scientific, Inc. The other players included in the value chain analysis (but not included in the report) are Assurex Health Inc., Teva Pharmaceutical Industries Ltd., and Bayer AG.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- [email protected]

Website- www.prophecymarketinsights.com